Apotex Inc. Acquires Topgen E.S.V. in Belgium from Zambon
"This acquisition represents an important milestone for Apotex International as it extends the organization's footprint in Europe and will be a launching pad for many E.U. products currently in the Apotex development pipeline," stated Andrew Kay, Apotex International President.
"The sale of Topgen furthers Zambon's strategy of focusing its Belgian operations on developing its portfolio of branded products, while simultaneously strengthening our relationship with Apotex, which is already a partner of Zambon and Chiesi in Italy through Doc Generici S.r.l.," explained Roberto Consonni, CEO of Zambon's Pharma Business.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.